Key facts
- It has raised $200K; the latest was Later Stage VC in Dec 2025.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, Impact Assets, Serra Ventures, Cleantech Open — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Imio
- ·The full record, as it builds
Funding rounds
No funding rounds for Imio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Imio
Developer of agricultural microbial inoculants designed to increase healthy crop yields. The company offers microbial inoculants that are all-natural, safe to handle, and regenerative that are designed to break down the plant matter, converting it to organic fertilizer, boosting plant growth, enabling clients to improve plant health, earn more revenue, and work with nature.
- Sector
- Materials and Resources
- HQ
- Hinesburg, VT, United States
- Founded
- 2018
- Employees
- 7
- Website
- imio.co/
- Ownership
- Privately Held (backing)
Imio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Imio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Imio in its N-PORT filings yet. We sweep new filings monthly.